Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2002-5-28
pubmed:abstractText
Cell adhesion to the extracellular matrix inhibits apoptosis, but the molecular mechanisms underlying the signals transduced by different matrix components are not well understood. Here, we examined integrin-mediated antiapoptotic signals from laminin-10/11 in comparison with those from fibronectin, the best characterized extracellular adhesive ligand. We found that the activation of protein kinase B/Akt in cells adhering to laminin-10/11 can rescue cell apoptosis induced by serum removal. Consistent with this, wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase, or ectopic expression of a dominant-negative mutant of Akt selectively accelerated cell death upon serum removal. In contrast to laminin-10/11, fibronectin rescued cells from serum depletion-induced apoptosis mainly through the extracellular signal-regulated kinase pathway. Cell survival on fibronectin but not laminin was significantly reduced by treatment with PD98059, a specific inhibitor of mitogen- or extracellular signal-regulated kinase kinase-1 (MEK1) and by expression of a dominant-negative mutant of MEK1. Laminin-10/11 was more potent than fibronectin in preventing apoptosis induced by serum depletion. These results, taken together, demonstrate laminin-10/11 potency as a survival factor and demonstrate that different extracellular matrix components can transduce distinct survival signals through preferential activation of subsets of multiple integrin-mediated signaling pathways.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/AKT1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Serum-Free, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Fibronectins, http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids, http://linkedlifedata.com/resource/pubmed/chemical/Integrins, http://linkedlifedata.com/resource/pubmed/chemical/Laminin, http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/MAP2K1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase..., http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides, http://linkedlifedata.com/resource/pubmed/chemical/PD 98059, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt, http://linkedlifedata.com/resource/pubmed/chemical/cystinyl-aspartyl-prolyl-glycyl-tyro..., http://linkedlifedata.com/resource/pubmed/chemical/laminin 10
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
277
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19922-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:11891225-Apoptosis, pubmed-meshheading:11891225-Blotting, Western, pubmed-meshheading:11891225-Cell Adhesion, pubmed-meshheading:11891225-Cell Survival, pubmed-meshheading:11891225-Culture Media, Serum-Free, pubmed-meshheading:11891225-Enzyme Inhibitors, pubmed-meshheading:11891225-Fibronectins, pubmed-meshheading:11891225-Flavonoids, pubmed-meshheading:11891225-Genes, Dominant, pubmed-meshheading:11891225-HeLa Cells, pubmed-meshheading:11891225-Humans, pubmed-meshheading:11891225-In Situ Nick-End Labeling, pubmed-meshheading:11891225-Integrins, pubmed-meshheading:11891225-Laminin, pubmed-meshheading:11891225-Ligands, pubmed-meshheading:11891225-MAP Kinase Kinase 1, pubmed-meshheading:11891225-Mitogen-Activated Protein Kinase Kinases, pubmed-meshheading:11891225-Mitogen-Activated Protein Kinases, pubmed-meshheading:11891225-Models, Biological, pubmed-meshheading:11891225-Mutation, pubmed-meshheading:11891225-Oligopeptides, pubmed-meshheading:11891225-Phosphatidylinositol 3-Kinases, pubmed-meshheading:11891225-Phosphorylation, pubmed-meshheading:11891225-Plasmids, pubmed-meshheading:11891225-Protein Binding, pubmed-meshheading:11891225-Protein-Serine-Threonine Kinases, pubmed-meshheading:11891225-Proto-Oncogene Proteins, pubmed-meshheading:11891225-Proto-Oncogene Proteins c-akt, pubmed-meshheading:11891225-Signal Transduction, pubmed-meshheading:11891225-Time Factors, pubmed-meshheading:11891225-Transfection, pubmed-meshheading:11891225-Tumor Cells, Cultured
pubmed:year
2002
pubmed:articleTitle
Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways.
pubmed:affiliation
Division of Protein Chemistry, Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
pubmed:publicationType
Journal Article